logo
EFFECT OF PANCREATIC WARM ISCHEMIA ON ISLET YIELD AND VIABILITY IN DOGS1
CHRONIC BLOCKADE OF CD28-B7-MEDIATED T-CELL COSTIMULATION BY CTLA4Ig REDUCES INTIMAL THICKENING IN MHC CLASS I AND II INCOMPATIBLE MOUSE HEART ALLOGRAFTS1,2
DONOR ANTIGEN IS NECESSARY FOR THE PREVENTION OF CHRONIC REJECTION IN CTLA4IG-TREATED MURINE CARDIAC ALLOGRAFT RECIPIENTS1,2
MODIFICATION OF HUMORAL RESPONSES BY THE COMBINATION OF LEFLUNOMIDE AND CYCLOSPORINE IN LEWIS RATS TRANSPLANTED WITH HAMSTER HEARTS1,2
IN VIVO CLASS II TRANSACTIVATOR EXPRESSION IN MICE IS INDUCED BY A NON-INTERFERON-γ MECHANISM IN RESPONSE TO LOCAL INJURY1,2
INDUCTION OF ALLOGRAFT NONRESPONSIVENESS AFTER INTRATHYMIC INOCULATION WITH DONOR CLASS I ALLOPEPTIDES
INDUCTION OF ALLOGRAFT NONRESPONSIVENESS AFTER INTRATHYMIC INOCULATION WITH DONOR CLASS I ALLOPEPTIDES
CONTRIBUTION OF ACTIVATED MACROPHAGES TO THE PROCESS OF DELAYED XENOGRAFT REJECTION1,2
IN VITRO ANALYSIS OF GADOLINIUM CHLORIDE ABROGATION OF THE SYSTEMIC TOLERANCE INDUCED BY PORTAL VENOUS ADMINISTRATION OF ULTRAVIOLET B-IRRADIATED DONOR CELLS1,2
LONG-TERM PANCREAS ALLOGRAFT OUTCOME IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION
MYCOPHENOLATE MOFETIL DECREASES REJECTION IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION WHEN COMBINED WITH TACROLIMUS OR CYCLOSPORINE1
DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1
A NOVEL APPROACH TO THE TREATMENT OF CHRONIC ALLOGRAFT NEPHROPATHY1
STUDY OF THE IN VITRO EFFECT ON GLOMERULAR ALBUMIN PERMSELECTIVITY OF SERUM BEFORE AND AFTER RENAL TRANSPLANTATION IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS1,2
POSTTRANSPLANT DIASTOLIC HYPERTENSION
COMPARATIVE STUDY OF CYTOMEGALOVIRUS (CMV) ANTIGENEMIA ASSAY, POLYMERASE CHAIN REACTION, SEROLOGY, AND SHELL VIAL ASSAY IN THE EARLY DIAGNOSIS AND MONITORING OF CMV INFECTION AFTER RENAL TRANSPLANTATION1
RESULTS OF RENAL TRANSPLANTATION IN PATIENTS WITH RENAL CELL CARCINOMA AND VON HIPPEL-LINDAU DISEASE1,2
NATIONAL IMPACT OF PULSATILE PERFUSION ON CADAVERIC KIDNEY TRANSPLANTATION1
USE OF GADOLINIUM-ENHANCED, ULTRAFAST, THREE-DIMENSIONAL, SPOILED GRADIENT-ECHO MAGNETIC RESONANCE ANGIOGRAPHY IN THE PREOPERATIVE EVALUATION OF LIVING RENAL ALLOGRAFT DONORS1
ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN KIDNEY TRANSPLANT PATIENTS RECEIVING TACROLIMUS (FK506)-BASED VERSUS CYCLOSPORINE-BASED IMMUNOSUPPRESSION1,2
PREDICTIVE VALUE OF ENZYME-LINKED IMMUNOSORBENT ASSAY-DETECTED IgG ANTI-HLA ANTIBODIES FOR PEDIATRIC RENAL ALLOGRAFT REJECTION1
RISK FACTORS FOR RENAL ALLOGRAFT SURVIVAL FROM OLDER CADAVER DONORS1
PREDNISONE WITHDRAWAL 14 DAYS AFTER LIVER TRANSPLANTATION WITH MYCOPHENOLATE
HEPATORENAL SYNDROME
CD40 AND CD40 LIGAND (CD154) ARE COEXPRESSED ON MICROVESSELS IN VIVO IN HUMAN CARDIAC ALLOGRAFT REJECTION1,2
SEROLOGIC RESPONSES TO HEPATITIS C VIRUS IN SOLID ORGAN TRANSPLANT RECIPIENTS1
USE OF RENAL ALLOGRAFTS FROM DONORS POSITIVE FOR HEPATITIS B CORE ANTIBODY CONFERS MINIMAL RISK FOR SUBSEQUENT DEVELOPMENT OF CLINICAL HEPATITIS B VIRUS DISEASE1
AN ANALYSIS OF DISCREPANCIES IN HLA PHENOTYPES OF CADAVER DONORS IN THE UNITED NETWORK FOR ORGAN SHARING REGISTRY1
HEALTH-RELATED FITNESS AND QUALITY OF LIFE IN ORGAN TRANSPLANT RECIPIENTS1,2
TEN YEARS OF LIVER TRANSPLANTATION
BLOCKADE OF THE CD40-CD40 LIGAND PATHWAY POTENTIATES THE CAPACITY OF DONOR-DERIVED DENDRITIC CELL PROGENITORS TO INDUCE LONG-TERM CARDIAC ALLOGRAFT SURVIVAL1,2
CD28-B7 T-CELL CO-STIMULATORY BLOCKADE POTENTIATES THE EFFECTS OF INTRATHYMIC IMMUNOMODULATION IN SENSITIZED GRAFT RECIPIENTS1,2
ROLE OF INDIRECT ALLORECOGNITION IN EXPERIMENTAL LATE ACUTE REJECTION1,2
MECHANISM OF FIBROSIS IN EXPERIMENTAL TACROLIMUS NEPHROTOXICITY1,2
PREVENTION OF CHRONIC REJECTION IN MOUSE AORTIC ALLOGRAFTS BY COMBINED TREATMENT WITH CTLA4-Ig AND ANTI-CD40 LIGAND MONOCLONAL ANTIBODY1,2
PROPHYLACTIC ORAL GANCICLOVIR COMPARED WITH DEFERRED THERAPY FOR CONTROL OF CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS1,2,†
PARVOVIRUS B19 INFECTION-RELATED COMPLICATIONS IN RENAL TRANSPLANT RECIPIENTS
THE GREAT SUCCESS OF ASIAN KIDNEY TRANSPLANT RECIPIENTS1,2
TACROLIMUS (FK506) AND SIROLIMUS (RAPAMYCIN) IN COMBINATION ARE NOT ANTAGONISTIC BUT PRODUCE EXTENDED GRAFT SURVIVAL IN CARDIAC TRANSPLANTATION IN THE RAT1,2
ANNOUNCEMENTS